Multiple receptors for dopamine

Pharmacological and biochemical criteria can be used to separate those dopamine receptors which are linked to the enzyme adenylyl cyclase and those which are not.

[1]  B. Roufogalis,et al.  Specificity of the dopamine sensitive adenylate cyclase for antipsychotic antagonists. , 1976, Life sciences.

[2]  M. Lipton,et al.  Psychopharmacology : a generation of progress , 1978 .

[3]  J. Kebabian,et al.  Dopamine-sensitive adenylate cyclase occurs in a region of substantia nigra containing dopaminergic dendrites. , 1976, Science.

[4]  R. Macleod,et al.  Studies on the mechanism of the dopamine-mediated inhibition of prolactin secretion. , 1974, Endocrinology.

[5]  N. Grant,et al.  Growth Hormone Releasing Factor of Microbial Origin , 1974, Nature.

[6]  P. Seeman,et al.  Anti-schizophrenic drugs--membrane receptor sites of action. , 1977, Biochemical pharmacology.

[7]  R. Macleod,et al.  Binding of dopamine to bovine anterior pituitary gland membranes. , 1978, Neuroendocrinology.

[8]  E. Mcgeer,et al.  Fine structural changes in the rat striatum after local injections of kainic acid , 1977, Brain Research.

[9]  S H Snyder,et al.  Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs , 1976, Science.

[10]  M. Caron,et al.  Dopaminergic receptors in the anterior pituitary gland. Correlation of [3H]dihydroergocryptine binding with the dopaminergic control of prolactin release. , 1978, The Journal of biological chemistry.

[11]  J. Hyttel,et al.  Effects of neuroleptics on 3H-haloperidol and 3H-cis(Z)-flupenthixol binding and on adenylate cyclase activity in vitro. , 1978, Life sciences.

[12]  E. Tolosa,et al.  Cholinergic effects of molecular segments of apomorphine and dopaminergic effects of N,N-dialkylated dopamines. , 1975, Journal of medicinal chemistry.

[13]  J. Clemens,et al.  Inhibition of rat prolactin release by apomorphine in vivo and in vitro. , 1974, Endocrinology.

[14]  G. Chiara,et al.  Haloperidol increases and apomorphine decreases striatal dopamine metabolism after destruction of striatal dopamine-sensitive adenylate cyclase by kainic acid , 1977, Brain Research.

[15]  W. Daughaday,et al.  Catecholamine inhibition of prolactin secretion by isolated rat adenohypophyses. , 1970, Endocrinology.

[16]  L. Iversen,et al.  Effects of dopamine-like drugs on rat striatal adenyl cyclase have implications for CNS dopamine receptor topography , 1974, Nature.

[17]  P. Greengard,et al.  Dopamine-sensitive adenylate cyclase in caudate nucleus of rat brain, and its similarity to the "dopamine receptor". , 1972, Proceedings of the National Academy of Sciences of the United States of America.

[18]  S. Snyder,et al.  Dopamine receptor binding: differentiation of agonist and antagonist states with 3H-dopamine and 3H-haloperidol. , 1975, Life sciences.

[19]  M. Schorderet.  Direct evidence for the stimulation of rabbit retina dopamine receptors by ergot alkaloids , 1976, Neuroscience Letters.

[20]  R. Macleod,et al.  Prolactin and growth hormone production as influenced by catecholamines and agents that affect brain catecholamines. , 1970, Neuroendocrinology.

[21]  W. Burkard,et al.  Effects of lisuride and LSD on cerebral monoamine systems and hallucinosis , 1978, Nature.

[22]  D. Rees.  PRE AND POSTSYNAPTIC RECEPTORS , 1976 .

[23]  B. Libet,et al.  Synaptic coupling into the production and storage of a neuronal memory trace , 1975, Nature.

[24]  H. Leitich,et al.  Antipsychotic drugs and dopamine-stimulated adenylate cyclase prepared from corpus striatum of rat brain. , 1974, Proceedings of the National Academy of Sciences of the United States of America.

[25]  L. Iversen.  Dopamine receptors in the brain. , 1975, Science.

[26]  R. George,et al.  Subcellular localization of dopamine-sensitive adenylate cyclase and dopamine receptor binding activities. , 1978, Life sciences.

[27]  M. Makman,et al.  Stimulation by dopamine of adenylate cyclase in retinal homogenates and of adenosine-3':5'-cyclic monophosphate formation in intact retina. , 1972, Proceedings of the National Academy of Sciences of the United States of America.

[28]  C. Marsden,et al.  Metoclopramide and dopamine receptor blockade , 1976, Neuropharmacology.

[29]  C. Kaiser,et al.  Studies on renal dopamine receptors with a new agonist. , 1978, European journal of pharmacology.

[30]  P. Greengard,et al.  Dopamine-sensitive adenylate cyclase in mammalian brain: a possible site of action of antipsychotic drugs. , 1974, Proceedings of the National Academy of Sciences of the United States of America.

[31]  O. Phillipson,et al.  Substantia nigra of the rat contains a dopamine sensitive adenylate cyclase , 1976, Nature.

[32]  H. Sarau,et al.  The central effects of a novel dopamine agonist. , 1978, European journal of pharmacology.

[33]  J. Kebabian.  Multiple classes of dopamine receptors in mammalian central nervous system: the involvement of dopamine-sensitive adenylyl cyclase. , 1978, Life sciences.

[34]  L. Iversen,et al.  Effect of butaclamol on dopamine‐sensitive adenylate cyclase in the rat striatum , 1975, The Journal of pharmacy and pharmacology.

[35]  P. Greengard,et al.  Dopamine-Sensitive Adenyl Cyclase: Possible Role in Synaptic Transmission , 1971, Science.

[36]  J. Hieble,et al.  Dopaminergic inhibition of adrenergic neurotransmission as a model for studies on dopamine receptor mechanisms. , 1978, Science.

[37]  P. Spano,et al.  Sulpiride: a study of the effects on dopamine receptors in rat neostriatum and limbic forebrain. , 1975, Life sciences.

[38]  J. Takahara,et al.  Effect of metoclopramide on rat prolactin secretion in vivo. , 1977, Life sciences.

[39]  L. I. Goldberg,et al.  A comparison of the vascular dopamine receptor with other dopamine receptors. , 1978, Annual review of pharmacology and toxicology.

[40]  P. Seeman,et al.  Dopamine receptors in human and calf brains, using [3H]apomorphine and an antipsychotic drug. , 1976, Proceedings of the National Academy of Sciences of the United States of America.

[41]  P. Seeman,et al.  New detection of brain dopamine receptors with (3H)dihydroergocryptine. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[42]  M. Schmidt,et al.  Effects of ergots on adenylate cyclase activity in the corpus striatum and pituitary. , 1977, Life sciences.

[43]  S. Snyder,et al.  3H-Spiroperidol labels dopamine receptors in pituitary and brain. , 1977, European journal of pharmacology.

[44]  E. Brown,et al.  Dopaminergic stimulation of cyclic AMP accumulation and parathyroid hormone release from dispersed bovine parathyroid cells. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[45]  J. Nutt,et al.  LONG-TERM TREATMENT OF PARKINSONISM WITH BROMOCRIPTINE , 1978, The Lancet.

[46]  P. Spano,et al.  Effects of bromocriptine on central dopaminergic receptors. , 1976, Life sciences.

[47]  S. Snyder,et al.  Dopamine receptors localised on cerebral cortical afferents to rat corpus striatum , 1978, Nature.

[48]  T. Pugsley,et al.  Effect of butaclamol and its enantiomers upon striatal homovanillic acid and adenyl cyclase of olfactory tubercle in rats. , 1975, Life sciences.